Trial
NCT05084560
Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Liverpool School of Tropical Medicine
Collaborators
Liverpool University Hospitals NHS Foundation Trust; Covance; Subiaco Associates Limited; Sylexis Limited; Eisai Limited
Condition
Filariasis, Lymphatic
Intervention
AWZ1066S
Why stopped
Safety issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-21